Physician

Sanjay Malhotra, MD

According to 2025 Medicare claims, Sanjay Malhotra, MD (NPI: 1548280084) practices cardiology in the Las Vegas-Henderson-North Las Vegas, NV market, with the plurality of this provider's patient population coming from Clark, NV. This provider's primary affiliated billing organization is NEVADA HEART AND VASCULAR CENTER RESH LLP (NPI: 1659387934; TIN: 200562668) and primary practice location at 89118-3035. Malhotra is affiliated with the Silver State ACO LLC (ACO ID: A2251), participating under the MSSP model.

Malhotra's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,072 traditional Medicare patients, billed 15,891 HCPCS/CPT codes, and received $1,333,904 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 6,594 prescription claims across 901 beneficiaries totaling $1,730,208 in drug costs, led by Eliquis (Apixaban). Open Payments data shows 81 records totaling $1,918. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $725,609 to $1,333,904. Similarly, Part D prescription costs have moved sharply higher in recent years, from $217,134 to $1,730,208. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,342	13,703	$725,609
2016	1,531	13,287	$743,823
2017	1,827	15,790	$845,429
2018	1,808	15,632	$963,638
2019	2,260	18,795	$1,055,892
2020	1,715	15,866	$1,115,713
2021	1,388	14,461	$1,232,483
2022	1,331	11,276	$1,178,081
2023	2,611	23,964	$2,006,244
2024	2,072	15,891	$1,333,904

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	298	2,895	$217,134
2016	336	3,404	$273,921
2017	396	3,492	$332,483
2018	485	3,847	$407,560
2019	555	4,349	$579,405
2020	618	4,698	$678,698
2021	640	4,897	$873,290
2022	686	5,222	$1,107,473
2023	790	5,568	$1,421,180
2024	901	6,594	$1,730,208

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	472	755	$88
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	577	996	$61
93015	Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician	490	492	$54
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	503	615	$10
J2785	Injection, regadenoson, 0.1 mg	449	1,794	$7

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	480	30,408	$587,729
Xarelto	Rivaroxaban	219	13,806	$250,003
Entresto	Sacubitril/Valsartan	193	8,829	$194,928
Camzyos	Mavacamten	21	630	$174,001
Repatha Sureclick	Evolocumab	174	9,060	$171,282

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	80	$1,658	Medtronic, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	1	$260	Medtronic, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Sanjay Malhotra, MD?

Tedicare shows public-source Medicare data for Sanjay Malhotra, MD (NPI 1548280084), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sanjay Malhotra, MD have ACO affiliation data?

Sanjay Malhotra, MD is shown with ACO affiliation data for Silver State ACO LLC (MSSP, ACO ID A2251).

What billing organization is linked to Sanjay Malhotra, MD?

Sanjay Malhotra, MD is linked to NEVADA HEART AND VASCULAR CENTER RESH LLP (billing NPI 1659387934) in the available physician profile data.

Does Sanjay Malhotra, MD have Open Payments data?

Sanjay Malhotra, MD has 81 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.